Back grey_arrow_rt.gif
 
 
Tamiflu Gets Additional EU Approval
 
 
  By THE ASSOCIATED PRESS
Published: January 31, 2006
 
Filed at 12:08 p.m. ET
 
BASEL, Switzerland (AP) -- The European Union has granted approval of Tamiflu for the prevention of influenza in children ages 1 through 12, the drug's manufacturer Roche Holding AG said Tuesday.
 
Tamiflu already has been approved for the treatment of influenza for adults and children older than 1, as well as for the prevention of influenza for those 13 years old and older. A similar approval for flu prevention in children was granted in the United States in December, Roche said.
 
''The influenza season is just starting in the northern hemisphere and Roche plans to make Tamiflu available to prevent influenza in very young children who are particularly vulnerable during an outbreak of the disease,'' said William Burns, chief executive of Roche's pharmaceuticals division.
 
''This is particularly helpful in the family setting when one member of the family catches influenza -- using Tamiflu for prevention will stop the spread of the disease to other family members,'' Burns added.
 
Experts also consider Tamiflu, or oseltamivir, the most efficient treatment in case of an outbreak of human influenza caused by a mutation of the bird flu virus H5N1, which has so far caused a deadly epidemic among birds.
 
 
 
 
  icon paper stack View Older Articles   Back to Top   www.natap.org